Literature DB >> 12164697

Zeptosens' protein microarrays: a novel high performance microarray platform for low abundance protein analysis.

Michael Pawlak1, Eginhard Schick, Martin A Bopp, Michael J Schneider, Peter Oroszlan, Markus Ehrat.   

Abstract

Protein microarrays are considered an enabling technology, which will significantly expand the scope of current protein expression and protein interaction analysis. Current technologies, such as two-dimensional gel electrophoresis (2-DE) in combination with mass spectrometry, allowing the identification of biologically relevant proteins, have a high resolving power, but also considerable limitations. As was demonstrated by Gygi et al. (Proc. Nat. Acad. Sci. USA 2000,97, 9390-9395), most spots in 2-DE, observed from whole cell extracts, are from high abundance proteins, whereas low abundance proteins, such as signaling molecules or kinases, are only poorly represented. Protein microarrays are expected to significantly expedite the discovery of new markers and targets of pharmaceutical interest, and to have the potential for high-throughput applications. Key factors to reach this goal are: high read-out sensitivity for quantification also of low abundance proteins, functional analysis of proteins, short assay analysis times, ease of handling and the ability to integrate a variety of different targets and new assays. Zeptosens has developed a revolutionary new bioanalytical system based on the proprietary planar waveguide technology which allows us to perform multiplexed, quantitative biomolecular interaction analysis with highest sensitivity in a microarray format upon utilizing the specific advantages of the evanescent field fluorescence detection. The analytical system, comprising an ultrasensitive fluorescence reader and microarray chips with integrated microfluidics, enables the user to generate a multitude of high fidelity data in applications such as protein expression profiling or investigating protein-protein interactions. In this paper, the important factors for developing high performance protein microarray systems, especially for targeting low abundant messengers of relevant biological information, will be discussed and the performance of the system will be demonstrated in experimental examples.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12164697     DOI: 10.1002/1615-9861(200204)2:4<383::AID-PROT383>3.0.CO;2-E

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  37 in total

Review 1.  Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions.

Authors:  Paola Picotti; Ruedi Aebersold
Journal:  Nat Methods       Date:  2012-05-30       Impact factor: 28.547

Review 2.  Multiplexed protein measurement: technologies and applications of protein and antibody arrays.

Authors:  Stephen F Kingsmore
Journal:  Nat Rev Drug Discov       Date:  2006-04       Impact factor: 84.694

Review 3.  Reverse phase protein microarrays advance to use in clinical trials.

Authors:  Claudius Mueller; Lance A Liotta; Virginia Espina
Journal:  Mol Oncol       Date:  2010-10-16       Impact factor: 6.603

4.  Focal molography is a new method for the in situ analysis of molecular interactions in biological samples.

Authors:  Volker Gatterdam; Andreas Frutiger; Klaus-Peter Stengele; Dieter Heindl; Thomas Lübbers; Janos Vörös; Christof Fattinger
Journal:  Nat Nanotechnol       Date:  2017-09-25       Impact factor: 39.213

5.  Evaluation of Protein Profiles From Treated Xenograft Tumor Models Identifies an Antibody Panel for Formalin-fixed and Paraffin-embedded (FFPE) Tissue Analysis by Reverse Phase Protein Arrays (RPPA).

Authors:  Sabine Bader; Magdalena Zajac; Thomas Friess; Elisabeth Ruge; Natascha Rieder; Berthold Gierke; Yvonne Heubach; Marlene Thomas; Michael Pawlak
Journal:  Mol Cell Proteomics       Date:  2015-06-23       Impact factor: 5.911

6.  Fabrication of a cyclic olefin copolymer planar waveguide embedded in a multi-channel poly(methyl methacrylate) fluidic chip for evanescence excitation.

Authors:  Paul I Okagbare; Jason M Emory; Proyag Datta; Jost Goettert; Steven A Soper
Journal:  Lab Chip       Date:  2009-11-04       Impact factor: 6.799

7.  Full dynamic range proteome analysis of S. cerevisiae by targeted proteomics.

Authors:  Paola Picotti; Bernd Bodenmiller; Lukas N Mueller; Bruno Domon; Ruedi Aebersold
Journal:  Cell       Date:  2009-08-06       Impact factor: 41.582

8.  Tracking humoral responses using self assembling protein microarrays.

Authors:  Niroshan Ramachandran; Karen S Anderson; Jacob V Raphael; Eugenie Hainsworth; Sahar Sibani; Wagner R Montor; Marcin Pacek; Jessica Wong; Mariam Eljanne; Martin G Sanda; Yanhui Hu; Tanya Logvinenko; Joshua Labaer
Journal:  Proteomics Clin Appl       Date:  2008-09-10       Impact factor: 3.494

9.  Realizing the promise of reverse phase protein arrays for clinical, translational, and basic research: a workshop report: the RPPA (Reverse Phase Protein Array) society.

Authors:  Rehan Akbani; Karl-Friedrich Becker; Neil Carragher; Ted Goldstein; Leanne de Koning; Ulrike Korf; Lance Liotta; Gordon B Mills; Satoshi S Nishizuka; Michael Pawlak; Emanuel F Petricoin; Harvey B Pollard; Bryan Serrels; Jingchun Zhu
Journal:  Mol Cell Proteomics       Date:  2014-04-28       Impact factor: 5.911

10.  Increasing the sensitivity of reverse phase protein arrays by antibody-mediated signal amplification.

Authors:  Jan C Brase; Heiko Mannsperger; Holger Fröhlich; Stephan Gade; Christian Schmidt; Stefan Wiemann; Tim Beissbarth; Thorsten Schlomm; Holger Sültmann; Ulrike Korf
Journal:  Proteome Sci       Date:  2010-06-22       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.